Altre lingue Cumberland Pharmaceuticals Inc.

Azioni

CPIX

US2307701092

Mercato chiuso - Nasdaq Altri mercati azionari 22:30:00 26/04/2024			Variaz. 5gg	Var. 1 gen.
1,76 ^USD	+3,53%		+10,00%	-1,77%

05/03	Cumberland Pharmaceuticals Inc. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
05/03	Transcript : Cumberland Pharmaceuticals Inc., 2023 Earnings Call, Mar 05, 2024

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS	02/04
Tranche Update on Cumberland Pharmaceuticals Inc.'s Equity Buyback Plan announced on May 13, 2010.	13/03
Cumberland Pharmaceuticals : CEO Message	12/03
Cumberland Pharmaceuticals : CEO Message	05/03
Cumberland Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	05/03
Cumberland: Q4 Earnings Snapshot	05/03
Cumberland Pharmaceuticals Reports Annual 2023 Financial Results	05/03
Cumberland Pharmaceuticals Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	05/03
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTS	27/02
Cumberland Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	07/11
Cumberland: Q3 Earnings Snapshot	07/11
Cumberland Pharmaceuticals Seeks Acquisitions	07/11
Earnings Flash (CPIX) CUMBERLAND PHARMACEUTICALS Reports Q3 EPS $0.02	07/11
Earnings Flash (CPIX) CUMBERLAND PHARMACEUTICALS Reports Q3 Revenue $10.1M	07/11
Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial Results	07/11
Tranche Update on Cumberland Pharmaceuticals Inc.'s Equity Buyback Plan announced on May 13, 2010.	07/11
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS	31/10/23
NEW VIBATV® PEDIATRIC PUBLICATION HIGHLIGHTS ITS SAFETY IN PATIENTS 2 TO 17 YEARS OF AGE	10/10/23
Cumberland Pharmaceuticals Inc. Announces New Antimicrobial Agents and Chemotherapy Detaining the Results of the First Clinical Study Investigating the Safety and Pharmacokinetics of Vibativ®? Injection in Children 2 to 17 Years of Age	10/10/23
Cumberland Pharmaceuticals Inc. Announces New Publication in Antimicrobial Agents and Chemotherapy Detaining the Safety and Pharmacokinetics of Vibativ Injection in Children 2 to 17 Years of Age	10/10/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Cumberland Pharmaceuticals Inc.

Azioni

CPIX

US2307701092

Altre lingue

Filtri